The government alleged Omnicare implemented an automated label verification system at certain locations that used less specific drug codes than the National Drug Code — a 10-digit number that identifies the labeler, product and trade package size. The use of less specific drug codes resulted in Omnicare submitting claims to Medicare and Medicaid for generic drugs that were not actually dispensed to beneficiaries, according to the DOJ.
The government also alleged Omnicare dispensed drugs with labels that displayed the incorrect manufacturer or National Drug Code.
The allegations against Omnicare were originally brought in a lawsuit filed under the qui tam, or whistle-blower, provisions of the False Claims Act.
More articles on healthcare industry lawsuits:
Florida physician convicted on 67 counts of Medicare fraud
IU Health, HealthNet pay $18M to resolve false billing allegations
Partners, Brigham and Women’s to pay $10M to settle research fraud suit
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.